FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889353619> ?p ?o ?g. }

• W2889353619 endingPage "4309" @default.
• W2889353619 startingPage "4295" @default.
• W2889353619 abstract "Background and purpose 3'-Sialyllactose (3'-SL) is a safe compound that is present in high levels in human milk. Although it has anti-inflammatory properties and supports immune homeostasis, its effect on collagen-induced arthritis (CIA) is unknown. In this study, we investigated the prophylactic and therapeutic effect of 3'-SL on the progression of rheumatoid arthritis (RA) in in vitro and in vivo models. Experimental approach The anti-arthritic effect of 3'-SL was analysed with fibroblast-like synoviocytes in vitro and an in vivo mouse model of CIA. RT-PCR, Western blotting and ELISA were performed to evaluate its effects in vitro. Histological analysis of ankle and knee joints of mice with CIA was performed using immunohistochemistry, as well as safranin-O and haematoxylin staining. Key results 3'-SL markedly alleviated the severity of CIA in the mice by reducing paw swelling, clinical scores, incidence rate, serum levels of inflammatory cytokines and autoantibody production. Moreover, 3'-SL reduced synovitis and pannus formation and suppressed cartilage destruction by blocking secretion of chemokines, pro-inflammatory cytokines, matrix metalloproteinases and osteoclastogenesis via NF-κB signalling. Notably, phosphorylation of p65, which is a key protein in the NF-κB signalling pathway, was totally blocked by 3'-SL in the RA models. Conclusions and implications 3'-SL ameliorated pathogenesis of CIA by suppressing catabolic factor expression, proliferation of inflammatory immune cells and osteoclastogenesis. These effects were mediated via blockade of the NF-κB signalling pathway. Therefore, 3'-SL exerted prophylactic and therapeutic effects and could be a novel therapeutic agent for the treatment of RA." @default.
• W2889353619 created "2018-09-07" @default.
• W2889353619 creator A5004345453 @default.
• W2889353619 creator A5005156445 @default.
• W2889353619 creator A5016483641 @default.
• W2889353619 creator A5030930195 @default.
• W2889353619 creator A5038806666 @default.
• W2889353619 creator A5047905932 @default.
• W2889353619 creator A5058250056 @default.
• W2889353619 creator A5066809606 @default.
• W2889353619 creator A5071917111 @default.
• W2889353619 creator A5072238416 @default.
• W2889353619 creator A5080068963 @default.
• W2889353619 creator A5081383124 @default.
• W2889353619 date "2018-10-17" @default.
• W2889353619 modified "2023-10-17" @default.
• W2889353619 title "3′-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis" @default.
• W2889353619 cites W1538894063 @default.
• W2889353619 cites W1593555249 @default.
• W2889353619 cites W1672953605 @default.
• W2889353619 cites W1888470382 @default.
• W2889353619 cites W1979928115 @default.
• W2889353619 cites W1995147873 @default.
• W2889353619 cites W2000468514 @default.
• W2889353619 cites W2002079143 @default.
• W2889353619 cites W2010802338 @default.
• W2889353619 cites W2011629178 @default.
• W2889353619 cites W2018475883 @default.
• W2889353619 cites W2036732971 @default.
• W2889353619 cites W2042587442 @default.
• W2889353619 cites W2047307433 @default.
• W2889353619 cites W2047711342 @default.
• W2889353619 cites W2050804496 @default.
• W2889353619 cites W2070282043 @default.
• W2889353619 cites W2079187903 @default.
• W2889353619 cites W2079245575 @default.
• W2889353619 cites W2081688565 @default.
• W2889353619 cites W2085099489 @default.
• W2889353619 cites W2087762274 @default.
• W2889353619 cites W2092099033 @default.
• W2889353619 cites W2098776090 @default.
• W2889353619 cites W2103819978 @default.
• W2889353619 cites W2111091679 @default.
• W2889353619 cites W2120962670 @default.
• W2889353619 cites W2125296092 @default.
• W2889353619 cites W2143660712 @default.
• W2889353619 cites W2154347931 @default.
• W2889353619 cites W2154749149 @default.
• W2889353619 cites W2155573803 @default.
• W2889353619 cites W2179421220 @default.
• W2889353619 cites W2341885578 @default.
• W2889353619 cites W2577319468 @default.
• W2889353619 cites W2599080348 @default.
• W2889353619 cites W2766306821 @default.
• W2889353619 cites W2771328536 @default.
• W2889353619 cites W2791033272 @default.
• W2889353619 cites W2791419854 @default.
• W2889353619 doi "https://doi.org/10.1111/bph.14486" @default.
• W2889353619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6240131" @default.
• W2889353619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30152858" @default.
• W2889353619 hasPublicationYear "2018" @default.
• W2889353619 type Work @default.
• W2889353619 sameAs 2889353619 @default.
• W2889353619 citedByCount "30" @default.
• W2889353619 countsByYear W28893536192019 @default.
• W2889353619 countsByYear W28893536192020 @default.
• W2889353619 countsByYear W28893536192021 @default.
• W2889353619 countsByYear W28893536192022 @default.
• W2889353619 countsByYear W28893536192023 @default.
• W2889353619 crossrefType "journal-article" @default.
• W2889353619 hasAuthorship W2889353619A5004345453 @default.
• W2889353619 hasAuthorship W2889353619A5005156445 @default.
• W2889353619 hasAuthorship W2889353619A5016483641 @default.
• W2889353619 hasAuthorship W2889353619A5030930195 @default.
• W2889353619 hasAuthorship W2889353619A5038806666 @default.
• W2889353619 hasAuthorship W2889353619A5047905932 @default.
• W2889353619 hasAuthorship W2889353619A5058250056 @default.
• W2889353619 hasAuthorship W2889353619A5066809606 @default.
• W2889353619 hasAuthorship W2889353619A5071917111 @default.
• W2889353619 hasAuthorship W2889353619A5072238416 @default.
• W2889353619 hasAuthorship W2889353619A5080068963 @default.
• W2889353619 hasAuthorship W2889353619A5081383124 @default.
• W2889353619 hasBestOaLocation W28893536191 @default.
• W2889353619 hasConcept C11960822 @default.
• W2889353619 hasConcept C126322002 @default.
• W2889353619 hasConcept C185592680 @default.
• W2889353619 hasConcept C2777575956 @default.
• W2889353619 hasConcept C502942594 @default.
• W2889353619 hasConcept C55493867 @default.
• W2889353619 hasConcept C71924100 @default.
• W2889353619 hasConcept C98274493 @default.
• W2889353619 hasConceptScore W2889353619C11960822 @default.
• W2889353619 hasConceptScore W2889353619C126322002 @default.
• W2889353619 hasConceptScore W2889353619C185592680 @default.
• W2889353619 hasConceptScore W2889353619C2777575956 @default.
• W2889353619 hasConceptScore W2889353619C502942594 @default.
• W2889353619 hasConceptScore W2889353619C55493867 @default.
• W2889353619 hasConceptScore W2889353619C71924100 @default.

• next